For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $60.07 in the prior trading day, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) closed at $59.77, down -0.50%. In other words, the price has decreased by -$0.50 from its previous closing price. On the day, 0.5 million shares were traded. RYTM stock price reached its highest trading level at $60.955 during the session, while it also had its lowest trading level at $59.36.
Ratios:
Our goal is to gain a better understanding of RYTM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.34 and its Current Ratio is at 3.49. In the meantime, Its Debt-to-Equity ratio is 22.73 whereas as Long-Term Debt/Eq ratio is at 22.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on October 21, 2024, initiated with a Buy rating and assigned the stock a target price of $70.
On September 18, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $64.
On September 17, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $64.JMP Securities initiated its Mkt Outperform rating on September 17, 2024, with a $64 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’24 when Lee Jennifer Kayden sold 66,861 shares for $66.33 per share. The transaction valued at 4,434,882 led to the insider holds 972 shares of the business.
Shulman Joseph sold 13,281 shares of RYTM for $882,341 on Nov 11 ’24. The Chief Technical Officer now owns 0 shares after completing the transaction at $66.44 per share. On Nov 11 ’24, another insider, JENNIFER KAYDEN LEE, who serves as the Officer of the company, bought 66,861 shares for $67.33 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RYTM now has a Market Capitalization of 3673291008 and an Enterprise Value of 3629650944. For the stock, the TTM Price-to-Sale (P/S) ratio is 32.64 while its Price-to-Book (P/B) ratio in mrq is 327.42. Its current Enterprise Value per Revenue stands at 32.255 whereas that against EBITDA is -13.753.
Stock Price History:
Over the past 52 weeks, RYTM has reached a high of $68.58, while it has fallen to a 52-week low of $29.38. The 50-Day Moving Average of the stock is 14.44%, while the 200-Day Moving Average is calculated to be 31.50%.
Shares Statistics:
The stock has traded on average 468.87K shares per day over the past 3-months and 945330 shares per day over the last 10 days, according to various share statistics. A total of 59.43M shares are outstanding, with a floating share count of 54.85M. Insiders hold about 10.74% of the company’s shares, while institutions hold 101.34% stake in the company. Shares short for RYTM as of 1730332800 were 8360239 with a Short Ratio of 17.83, compared to 1727654400 on 8234954. Therefore, it implies a Short% of Shares Outstanding of 8360239 and a Short% of Float of 20.57.
